A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Year: 2020
Type: conference-abstract
Source: Blood
Institutions: Takeda Oncology (United States), Children's Hospital Colorado, University of Colorado Anschutz, University of California, San Francisco, University of California San Francisco Medical Center, UCSF Helen Diller Family Comprehensive Cancer Center, St. Jude Children's Research Hospital, University of Milano-Bicocca, Boston Children's Hospital, Dana-Farber Cancer Institute
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096640619